Results 261 to 270 of about 198,724 (360)

MicroRNA and Protein Biomarkers of Intestinal Permeability in the Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). [PDF]

Int J Mol Sci
Białek D, Wunsch E, Kempińska-Podhorodecka A, Abramczyk J, Wunsch A, Kozłowska K.   +5 more
europepmc   +1 more source

Aerobic exercise improved liver steatosis by modulating miR-34a-mediated PPARα/SIRT1-AMPK signaling pathway. [PDF]

PLoS One
Wu B, Zhang Z, Xu C, Zhao J.
europepmc   +1 more source

Host‐driven hepatic conversion of gut microbiota‐derived putrescine to spermidine mediates mannose's protective effects against hepatic steatosis in zebrafish

iMeta, EarlyView.
Evidence for liver metabolism of gut‐derived microbial compounds into beneficial secondary metabolites has been lacking. Here, we demonstrate that Cetobacterium somerae (C. somerae), enriched by mannose supplementation under high‐fat diet conditions, convert arginine into putrescine.
Delong Meng, Zhen Zhang, Tsegay Teame, Benjamin Earl Niemann, Rui Xia, Shichang Xu, Yajie Zhao, Yalin Yang, Chao Ran, Le Luo Guan, Zhigang Zhou   +10 more
wiley   +1 more source

Retraction: Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

IMM‐H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high‐fat diet

, 2017
Huijie Shi, Qingchun Wang, Yang Liu, Shouxia Xie, Haibo Zhu   +4 more
openalex   +1 more source

Non‐Nutritive Artificial Sweeteners Aspartame and Acesulfame‐K Ameliorate Metabolic Dysfunction‐Associated Steatotic Liver Disease in Male Ldlr−/− Mice

iNew Medicine, EarlyView.
ABSTRACT Aspartame and acesulfame‐K are commonly used non‐nutritive artificial sweeteners, but their impacts on cardiovascular disease and metabolic dysfunction‐associated fatty liver disease (MASLD) are unclear. In this study, we evaluated the impacts of aspartame and acesulfame‐K on MASLD and atherosclerosis in male Ldlr−/− mice fed an AMLN diet ...
Jingjing Xu, Xiaohua Jiang, Jianping Weng, Suowen Xu   +3 more
wiley   +1 more source

Poor Sensitivity of the Fatty Liver Index Among Lean Individuals. [PDF]

Am J Gastroenterol
Shaik MR, Rotman Y.
europepmc   +1 more source

miR-155 modulates fatty acid accumulation by targeting C/EBPβ in free fatty acid-induced steatosis in HepG2 cells

, 2019
Jun Hu, Xiaohong Chen
openalex   +1 more source

Prospective Comparison of DWI‐Derived Virtual MR Elastography and Conventional MR Elastography in Metabolic Dysfunction‐Associated Steatotic Liver Disease and Healthy Volunteers

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Virtual MR elastography (VMRE) and MRE have been proposed for liver fibrosis staging in metabolic dysfunction‐associated steatotic liver disease (MASLD), but VMRE's diagnostic performance remains debated. Purpose To assess the inter‐visit and inter‐reader reproducibility of fat‐uncorrected and fat‐corrected diffusion‐weighted ...
Anton Volniansky, Thierry L. Lefebvre, Merve Kulbay, Guillaume Gilbert, Boyan Fan, Justine Racette, Emmanuel Montagnon, Damien Olivié, Giada Sebastiani, Jeanne‐Marie Giard, Marie‐Pierre Sylvestre, Bich Ngoc Nguyen, Guy Cloutier, An Tang   +13 more
wiley   +1 more source

Ultrasound-derived fat fraction for the noninvasive quantification of hepatic steatosis: a prospective multicenter study. [PDF]

Insights Imaging
Xue L, Zhu Y, Cheng G, Han H, He N, Chen L, Ma Z, Ge H, Jiang D, He T, Shen R, Jiang W, Sun L, Zhang J, Cai X, Xu H, Ding H.   +16 more
europepmc   +1 more source